Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

90°
- Benton, AR (72018)
  Today
  
  Clear skies. Low 74F. Winds SSW at 5 to 10 mph..
  
  Tonight
  
  Clear skies. Low 74F. Winds SSW at 5 to 10 mph.
  
  Updated: June 9, 2026 @ 5:49 pm
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2026
Community Calendar

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

HUTCHMED (China) Limited - American Depositary Shares (NQ:HCM)

10.90 +0.27 (+2.59%)

Streaming Delayed Price Updated: 2:28 PM EDT, Jun 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HUTCHMED (China) Limited - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer

November 08, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

CRISPR Therapeutics Stock Earns IBD Stock Rating Upgrade ↗

November 08, 2023

On Wednesday, CRISPR Therapeutics stock had its Relative Strength (RS) Rating upgraded to 85, up from 68 a day earlier.

Via Investor's Business Daily

Rocket Pharmaceuticals Stock Sees Improved Price Strength ↗

November 02, 2023

On Thursday, Rocket Pharmaceuticals stock got an upgrade to its Relative Strength (RS) Rating, from 68 to 78

Via Investor's Business Daily

International companies to host live webcasts at Deutsche Bank’s Depositary Receipts

November 01, 2023

Virtual Investor Conference on November 8th and 9th, 2023

From Virtual Investor Conferences

Via GlobeNewswire

Apellis Pharmaceuticals Stock Improves With An RS Ratings Over 90 ↗

October 31, 2023

Apellis Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 30, 2023

Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.

Via Benzinga

Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday ↗

October 30, 2023

U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Rocket Pharmaceuticals Stock Sees RS Rating Pops Higher ↗

October 27, 2023

A Relative Strength Rating upgrade for Rocket Pharmaceuticals shows improving technical performance. Will it continue?

Via Investor's Business Daily

Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday ↗

October 27, 2023

U.S. stocks traded mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Apellis Pharmaceuticals Stock Shows Rising Relative Strength ↗

October 24, 2023

A Relative Strength Rating upgrade for Apellis Pharmaceuticals shows improving technical performance. Will it continue?

Via Investor's Business Daily

Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90 ↗

October 16, 2023

Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2023

October 16, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

AZZ, VOXX International And Other Big Stocks Moving Higher On Wednesday ↗

October 11, 2023

U.S. stocks traded higher Wednesday, with the Dow Jones gaining around 100 points. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Sarepta Therapeutics Stock Showing Rising Relative Strength ↗

October 09, 2023

Sarepta Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Via Investor's Business Daily

HUTCHMED Announces Submission of New Drug Application for Fruquintinib for Previously Treated Metastatic Colorectal Cancer in Japan

September 29, 2023

— Third major market authorization application based on data from the FRESCO-2 global Phase III trial —

From HUTCHMED (China) Limited

Via GlobeNewswire

Amicus Therapeutics Stock Reaches 80+ Relative Strength Benchmark ↗

September 28, 2023

Amicus Therapeutics sees its Relative Strength Rating move into the 80-plus level.

Via Investor's Business Daily

Axsome Therapeutics Stock Clears Key Benchmark, Hits 80-Plus RS Rating ↗

September 27, 2023

A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance.

Via Investor's Business Daily

HUTCHMED Highlights Presentation of Results from the Phase IIIb Trial of Savolitinib at the 2023 World Conference of Lung Cancer

September 12, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

HUTCHMED Completes Patient Enrollment of a Bridging Study of Tazemetostat in Patients with Relapsed/Refractory Follicular Lymphoma in China

September 11, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

Tesla, Crinetics Pharmaceuticals And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

September 11, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

HUTCHMED Receives Breakthrough Therapy Designation in China for Savolitinib for Gastric Cancer

August 28, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca ↗

August 26, 2023

China’s drug distributors are in the hunt to acquire Poland’s Neuca, a company with a 32% market share of Poland’s pharmaceutical distribution business. The consortium of China’s drug distributors may...

Via Talk Markets

Hutchmed's Candidate Achieves Main Goal In China's Rare Blood Disorder Study ↗

August 21, 2023

HUTCHMED (China) Limited's (NASDAQ: HCM) pivotal Phase 3 trial ESLIM-01 evaluating the investigational use of sovleplenib met its primary endpoint of durable response rate and all secondary endpoints...

Via Benzinga

HUTCHMED Announces that the Sovleplenib Phase III ESLIM-01 Study Met Its Primary Endpoint in Primary Immune Thrombocytopenia in China

August 20, 2023

From HUTCHMED (China) Limited

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 07, 2023

Via Benzinga

Why Kosmos Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

August 07, 2023

Gainers Save Foods, Inc. (NASDAQ: SVFD) shares surged 76.6% to $1.13 in pre-market trading after gaining 15% on Friday.

Via Benzinga

Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 07, 2023

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

August 07, 2023

It's time to start off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning!

Via InvestorPlace

Sohu.com, Cloudflare And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

August 07, 2023

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. HUTCHMED (China) Limited (NYSE: HCM) shares dipped 14.1% to...

Via Benzinga

Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 01, 2023

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

HUTCHMED (China) Limited - American Depositary Shares (NQ:HCM)

All News about HUTCHMED (China) Limited - American Depositary Shares

Sections

Services

Follow Us